Related Experiment Videos
Improving the detection of coeliac disease
The Practitioner
|October 11, 2017
Summary
Coeliac disease diagnosis in adults requires serology and biopsy, with IgA-tissue transglutaminase antibody testing as the first step. A strict gluten-free diet is the only treatment, necessitating dietitian support and regular follow-up.
Area of Science:
- Gastroenterology
- Immunology
- Internal Medicine
Background:
- Coeliac disease presentation has evolved from childhood malabsorption to diverse adult symptoms like IBS, anemia, fatigue, and osteoporosis.
- Accurate diagnosis in adults relies on a combination of serological tests and duodenal biopsy.
- The shift necessitates updated diagnostic and management strategies for coeliac disease.
Purpose of the Study:
- To outline the current diagnostic pathway for coeliac disease in adults.
- To emphasize the importance of specific investigations and dietary adherence.
- To provide guidance on the management and follow-up of adult coeliac disease patients.
Main Methods:
- First-line screening involves IgA-tissue transglutaminase antibody testing.
- A gluten-containing diet for six weeks prior to testing is crucial for accurate results.
- Confirmatory diagnosis requires a mandatory duodenal biopsy.
Main Results:
- IgA-tissue transglutaminase antibody testing is the recommended initial screening method.
- Maintaining a gluten-containing diet before investigation ensures reliable serological and histological findings.
- Duodenal biopsy is essential for definitive coeliac disease diagnosis.
Conclusions:
- Adult coeliac disease diagnosis requires a dual approach: serology and biopsy.
- Lifelong adherence to a strict gluten-free diet is the cornerstone of coeliac disease management.
- Specialist dietitian support and annual follow-up are vital for stable disease management.